 John Perry
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 14 | 2023 | 22 | 2.790 |
Why?
| | beta Catenin | 3 | 2020 | 9 | 1.350 |
Why?
| | Stem Cell Niche | 2 | 2023 | 2 | 1.330 |
Why?
| | PTEN Phosphohydrolase | 3 | 2020 | 7 | 1.200 |
Why?
| | Wnt Proteins | 2 | 2020 | 11 | 1.160 |
Why?
| | Leukemia | 3 | 2023 | 17 | 1.130 |
Why?
| | Neoplastic Stem Cells | 2 | 2023 | 10 | 0.980 |
Why?
| | Animals | 18 | 2022 | 563 | 0.930 |
Why?
| | Mice | 15 | 2022 | 290 | 0.850 |
Why?
| | Cell Differentiation | 5 | 2020 | 41 | 0.830 |
Why?
| | Cell Proliferation | 5 | 2020 | 55 | 0.770 |
Why?
| | Doxorubicin | 1 | 2020 | 17 | 0.750 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2020 | 9 | 0.740 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 27 | 0.740 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 114 | 0.680 |
Why?
| | Signal Transduction | 5 | 2015 | 107 | 0.590 |
Why?
| | Stem Cell Factor | 1 | 2012 | 1 | 0.430 |
Why?
| | Biological Assay | 1 | 2010 | 3 | 0.370 |
Why?
| | Apoptosis | 3 | 2020 | 43 | 0.370 |
Why?
| | Humans | 11 | 2023 | 6599 | 0.340 |
Why?
| | F-Box Proteins | 1 | 2008 | 1 | 0.330 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2008 | 9 | 0.330 |
Why?
| | Cell Cycle Proteins | 1 | 2008 | 15 | 0.330 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 14 | 0.330 |
Why?
| | Myeloproliferative Disorders | 1 | 2007 | 11 | 0.310 |
Why?
| | Mice, Knockout | 4 | 2020 | 54 | 0.300 |
Why?
| | Cells, Cultured | 5 | 2017 | 73 | 0.280 |
Why?
| | Stem Cells | 2 | 2019 | 19 | 0.270 |
Why?
| | Mice, Inbred C57BL | 6 | 2018 | 76 | 0.260 |
Why?
| | Mutation | 5 | 2017 | 194 | 0.260 |
Why?
| | Cadherins | 2 | 2019 | 6 | 0.260 |
Why?
| | RNA, Long Noncoding | 2 | 2015 | 14 | 0.250 |
Why?
| | Adult Stem Cells | 2 | 2013 | 2 | 0.240 |
Why?
| | Immune System | 1 | 2023 | 4 | 0.230 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 14 | 0.230 |
Why?
| | Sphingosine | 1 | 2022 | 1 | 0.220 |
Why?
| | Acute Radiation Syndrome | 1 | 2022 | 1 | 0.220 |
Why?
| | Cell Lineage | 2 | 2020 | 17 | 0.210 |
Why?
| | Cell Cycle | 2 | 2014 | 14 | 0.210 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2020 | 1 | 0.190 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2020 | 8 | 0.190 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 14 | 0.190 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 24 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2020 | 9 | 0.190 |
Why?
| | Epigenesis, Genetic | 2 | 2018 | 64 | 0.190 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2011 | 50 | 0.180 |
Why?
| | Phenotype | 2 | 2011 | 233 | 0.180 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2017 | 5 | 0.180 |
Why?
| | Stromal Cells | 1 | 2019 | 2 | 0.170 |
Why?
| | Cell Self Renewal | 1 | 2018 | 1 | 0.170 |
Why?
| | Adenosine | 1 | 2018 | 8 | 0.170 |
Why?
| | RNA-Binding Proteins | 1 | 2018 | 5 | 0.170 |
Why?
| | Biomarkers | 2 | 2010 | 120 | 0.170 |
Why?
| | Retinoids | 1 | 2018 | 1 | 0.170 |
Why?
| | Hematopoiesis | 1 | 2018 | 3 | 0.170 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 18 | 0.160 |
Why?
| | Megakaryocytes | 2 | 2014 | 3 | 0.160 |
Why?
| | RNA, Ribosomal | 1 | 2017 | 3 | 0.160 |
Why?
| | Models, Biological | 2 | 2008 | 46 | 0.150 |
Why?
| | Genomic Imprinting | 2 | 2015 | 7 | 0.150 |
Why?
| | DNA Copy Number Variations | 1 | 2017 | 31 | 0.150 |
Why?
| | Male | 3 | 2020 | 3197 | 0.140 |
Why?
| | Female | 3 | 2020 | 3436 | 0.140 |
Why?
| | Mitochondria | 1 | 2015 | 9 | 0.140 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2015 | 11 | 0.140 |
Why?
| | Genetic Loci | 1 | 2015 | 37 | 0.140 |
Why?
| | Cell Culture Techniques | 2 | 2013 | 5 | 0.130 |
Why?
| | MicroRNAs | 2 | 2015 | 26 | 0.130 |
Why?
| | Regeneration | 1 | 2014 | 3 | 0.130 |
Why?
| | Homeostasis | 1 | 2014 | 7 | 0.130 |
Why?
| | Bone Marrow Cells | 3 | 2012 | 6 | 0.130 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2013 | 1 | 0.120 |
Why?
| | Antigens, Surface | 1 | 2013 | 2 | 0.120 |
Why?
| | Intestinal Mucosa | 1 | 2013 | 34 | 0.110 |
Why?
| | Hematopoietic System | 1 | 2012 | 1 | 0.110 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2012 | 3 | 0.110 |
Why?
| | Fibroblast Growth Factors | 1 | 2012 | 27 | 0.110 |
Why?
| | Gene Knock-In Techniques | 1 | 2012 | 4 | 0.110 |
Why?
| | Cell Line | 1 | 2011 | 80 | 0.100 |
Why?
| | Embryonic Stem Cells | 1 | 2011 | 7 | 0.100 |
Why?
| | Osteoblasts | 2 | 2008 | 21 | 0.100 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 98 | 0.100 |
Why?
| | Reactive Oxygen Species | 2 | 2022 | 6 | 0.090 |
Why?
| | Gene Deletion | 1 | 2008 | 12 | 0.080 |
Why?
| | Fluorouracil | 3 | 2014 | 4 | 0.080 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2008 | 39 | 0.080 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2007 | 9 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2013 | 26 | 0.080 |
Why?
| | HEK293 Cells | 2 | 2018 | 30 | 0.080 |
Why?
| | Prolyl Hydroxylases | 1 | 2022 | 1 | 0.060 |
Why?
| | Glycolysis | 1 | 2022 | 4 | 0.060 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2022 | 2 | 0.060 |
Why?
| | Bone Marrow | 1 | 2022 | 6 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 11 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-kit | 2 | 2013 | 5 | 0.050 |
Why?
| | Germ Cells | 1 | 2020 | 5 | 0.050 |
Why?
| | Pluripotent Stem Cells | 1 | 2020 | 5 | 0.050 |
Why?
| | Down-Regulation | 1 | 2020 | 14 | 0.050 |
Why?
| | Protein Binding | 1 | 2020 | 30 | 0.050 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 13 | 0.050 |
Why?
| | Transcription Factors | 1 | 2020 | 46 | 0.050 |
Why?
| | Antimetabolites, Antineoplastic | 2 | 2012 | 23 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 64 | 0.050 |
Why?
| | Enhancer Elements, Genetic | 1 | 2018 | 18 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 3 | 0.040 |
Why?
| | DNA Damage | 1 | 2017 | 6 | 0.040 |
Why?
| | Organelle Biogenesis | 1 | 2015 | 1 | 0.030 |
Why?
| | Antigens, CD | 1 | 2015 | 8 | 0.030 |
Why?
| | Acetylcysteine | 1 | 2015 | 9 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2015 | 9 | 0.030 |
Why?
| | Sirolimus | 1 | 2015 | 8 | 0.030 |
Why?
| | Fetus | 1 | 2015 | 16 | 0.030 |
Why?
| | Fibroblast Growth Factor 1 | 1 | 2014 | 1 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2014 | 10 | 0.030 |
Why?
| | Liver | 1 | 2015 | 119 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2014 | 6 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2014 | 23 | 0.030 |
Why?
| | Receptor, IGF Type 1 | 1 | 2013 | 2 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2013 | 8 | 0.030 |
Why?
| | Activated-Leukocyte Cell Adhesion Molecule | 1 | 2013 | 1 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 2 | 0.030 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 6 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 33 | 0.030 |
Why?
| | Colon | 1 | 2013 | 12 | 0.030 |
Why?
| | Intestine, Small | 1 | 2013 | 14 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2012 | 4 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2012 | 36 | 0.030 |
Why?
| | NF-kappa B | 1 | 2012 | 14 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2012 | 33 | 0.030 |
Why?
| | Cell Movement | 1 | 2012 | 21 | 0.030 |
Why?
| | Gene Expression | 1 | 2012 | 60 | 0.030 |
Why?
| | Myoblasts | 1 | 2011 | 2 | 0.030 |
Why?
| | Neural Stem Cells | 1 | 2011 | 5 | 0.030 |
Why?
| | Organ Specificity | 1 | 2011 | 22 | 0.030 |
Why?
| | Ataxins | 1 | 2008 | 1 | 0.020 |
Why?
| | Ataxin-1 | 1 | 2008 | 1 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 4 | 0.020 |
Why?
| | Mice, Nude | 1 | 2008 | 10 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 27 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 65 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 45 | 0.020 |
Why?
| | Base Sequence | 1 | 2008 | 76 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 24 | 0.020 |
Why?
| | Spleen | 1 | 2008 | 29 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2008 | 45 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2008 | 107 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 109 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|